Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Dressler

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Rheumatology International|June 8, 2023
Incident psoriasis under treatment with tumor necrosis factor-α inhibitors in juvenile idiopathic arthritis patients-analysis of the BiKeR registryAngela Zimmer, Ariane Klein, Jasmin B Kuemmerle-Deschner, et al.
Rheumatology (Oxford, England)|October 12, 2022
Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survivalFranz Thiele, Ariane Klein, Jens Klotsche, et al.
Arthritis Research & Therapy|October 30, 2020
Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registryGiulia Armaroli, Ariane Klein, Gerd Ganser, et al.
Rheumatology (Oxford, England)|September 2, 2017
Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increaseAnne-Marie Knieper, Jens Klotsche, Elke Lainka, et al.
RMD Open|April 9, 2026
Emotional well-being at diagnosis may indicate future mental health risk in patients with juvenile idiopathic arthritis: data from the German inception cohort ICONPrasad T Oommen, Jens Klotsche, Rainer Berendes, et al.
Frontiers in Genetics|February 13, 2023
Systematic genetic analysis of pediatric patients with autoinflammatory diseasesYvonne Poker, Sandra von Hardenberg, Winfried Hofmann, et al.
ACR Open Rheumatology|January 17, 2020
Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long-Term Safety Data from the German BIKER RegistryAriane Klein, Ingrid Becker, Kirsten Minden, et al.
Arthritis Research & Therapy|March 21, 2025
Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) studyKaroline Baquet-Walscheid, Kirsten Minden, Martina Niewerth, et al.
Pediatric Rheumatology Online Journal|April 18, 2024
Risk perception, well-being, depression and anxiety in children and adolescents with rheumatic diseases during the COVID-19 pandemic - results from the prospective multicenter KICK-COVID study in GermanyClaudia Sengler, Jens Klotsche, Malthe Jessen Pedersen, et al.
Pediatric Rheumatology Online Journal|June 27, 2018
Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and AustriaClaas H Hinze, Prasad T Oommen, Frank Dressler, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Rheumatology International|June 8, 2023
Incident psoriasis under treatment with tumor necrosis factor-α inhibitors in juvenile idiopathic arthritis patients-analysis of the BiKeR registryAngela Zimmer, Ariane Klein, Jasmin B Kuemmerle-Deschner, et al.
Rheumatology (Oxford, England)|October 12, 2022
Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survivalFranz Thiele, Ariane Klein, Jens Klotsche, et al.
Arthritis Research & Therapy|October 30, 2020
Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registryGiulia Armaroli, Ariane Klein, Gerd Ganser, et al.
Rheumatology (Oxford, England)|September 2, 2017
Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increaseAnne-Marie Knieper, Jens Klotsche, Elke Lainka, et al.
RMD Open|April 9, 2026
Emotional well-being at diagnosis may indicate future mental health risk in patients with juvenile idiopathic arthritis: data from the German inception cohort ICONPrasad T Oommen, Jens Klotsche, Rainer Berendes, et al.
Frontiers in Genetics|February 13, 2023
Systematic genetic analysis of pediatric patients with autoinflammatory diseasesYvonne Poker, Sandra von Hardenberg, Winfried Hofmann, et al.
ACR Open Rheumatology|January 17, 2020
Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long-Term Safety Data from the German BIKER RegistryAriane Klein, Ingrid Becker, Kirsten Minden, et al.
Arthritis Research & Therapy|March 21, 2025
Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) studyKaroline Baquet-Walscheid, Kirsten Minden, Martina Niewerth, et al.
Pediatric Rheumatology Online Journal|April 18, 2024
Risk perception, well-being, depression and anxiety in children and adolescents with rheumatic diseases during the COVID-19 pandemic - results from the prospective multicenter KICK-COVID study in GermanyClaudia Sengler, Jens Klotsche, Malthe Jessen Pedersen, et al.
Pediatric Rheumatology Online Journal|June 27, 2018
Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and AustriaClaas H Hinze, Prasad T Oommen, Frank Dressler, et al.
Pageof 5